Medallion Financial
MFIN · NASDAQ
About MFIN
- Employees
- 179
- Headquarters
- New York City, New York
- Listed
- May 23, 1996
- Sector
- Financials
- Industry
- Consumer Finance
- Website
- medallion.com
MFIN key statistics
- Market cap
- 257.15M
- Price-earnings ratio
- 8.44
- Dividend yield
- 4.57%
- Average volume
- 64.77K
- Volume
- 30.79K
- Open price
- $11.15
- High today
- $11.46
- Low today
- $11.00
- 52 Week high
- $12.26
- 52 Week low
- $7.85
Medallion Financial (MFIN) at a glance
As of Oct 20, 2026, Medallion Financial (MFIN) shares are priced at $11.20, giving the company a market cap of 257.15M, a price-to-earnings ratio of 8.44 and a dividend yield of 4.57%.
Today the stock has traded between $11.00 and $11.46. The current price is 1.8% above the day's low and 2.2% below its high.
Volume so far is 30.79K shares, below the average of 64.77K shares a day.
Over the past year Medallion Financial has ranged from $7.85 to $12.26, and now sits 76% of the way up that range.
Medallion Financial met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.31 per share against an estimate of $0.2915.
The average analyst price target is $11.22, 0.2% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold100.0%
- Sell0.0%
- Low
- $10.60
- Now
- $11.20
- High
- $12.60
MFIN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 26.4% on average.
- Q3 FY24: reported $0.37 per share against an estimate of $0.3808
- Q4 FY24: reported $0.55 per share against an estimate of $0.3774
- Q1 FY25: reported $0.50 per share against an estimate of $0.3723
- Q2 FY25: reported $0.41 per share against an estimate of $0.3213
- Q3 FY25: reported $0.32 per share against an estimate of $0.3519
- Q4 FY25: reported $0.50 per share against an estimate of $0.4233
- Q1 FY26: reported $0.20 per share against an estimate of $0.3417
- Q2 FY26: reported $0.31 per share against an estimate of $0.2915
MFIN news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
ZimCal (BIMIZCI) Exposes Medallion Financial Corp.'s Latest Campaign of Distortion and the Risks of Re-Electing Its Unqualified Directors
- Press releaseBusiness Wire
BIMIZCI Urges Stockholders to Vote for Its Outstanding Nominees to the Board Who Will Strengthen Medallion and Represent Stockholders. MFIN Wants to Distract from Underlying Underperformance and Possible Dividend Issues – We Won't Let Them.
- Press releaseBusiness Wire
ISS and Glass Lewis Support BIMIZCI's Case for Change at Medallion Financial. Both Recommend Stockholders Vote on the BLUE Proxy Card FOR Election of Two BIMIZCI Nominees to Medallion Board
- Press releaseBusiness Wire
The Written Record Disproved Medallion Financial Statements Before. It Does So Again. BIMIZCI Issues Point-by-Point Rebuttal of Medallion's Investor Presentation. Urges Stockholders to Vote for Change
- Press releaseGlobe Newswire
Medallion Financial Corp. Urges Shareholders to Vote for Its Highly Qualified Director Nominees Ahead of 2026 Annual Meeting
- Press releaseBusiness Wire
BIMIZCI Crosses 500,000 Share Threshold; Nominates Three Directors at Medallion Financial; Cites Deteriorating Performance, and Federal Securities Fraud Judgment
'NY Wins Bid to Stop US From Withholding Funds Over Congestion' - Bloomberg News
Similar companies
Companies in the same industry as Medallion Financial
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.